Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome

Mara G. Coyle,Songthip T. Ounpraseuth,Barry Lester,Lynne M. Dansereau,Zhuopei Hu,Abbot Laptook,Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network and the NIH Environmental Influences on Child Health Outcomes (ECHO) Program Institutional Development Awards States Pediatric Clinical Trials Network,Abbot Laptook,Songthip T. Ounpraseuth,Zhuopei Hu

DOI: https://doi.org/10.1038/s41372-024-02144-6

2024-10-16

Journal of Perinatology

Abstract:To predict pharmacotherapy for NOWS based on factors available shortly after birth. A multi-center, retrospective study of 1377 opioid exposed newborns between 2016 and 2017 dichotomized based on pharmacologic treatment ( N = 665 treated, N = 712 not treated) was conducted. A multilevel mixed-effect logistic regression model that considered cluster effect from sites determined significant maternal and newborn factors associated with pharmacotherapy, which were combined in a nomogram to predict probability of treatment for infants at each participating site.

pediatrics,obstetrics & gynecology